← Open Payments lookup

JEFFREY ELFENBEIN: Open Payments

NPI 1043308695 · SEAFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,094 in 55 payments from 14 companies in 2025. Trend: 2023 $3,129 · 2024 $1,950 · 2025 $1,094

Food & beverage: $1,094
CompanyPaymentsAmount
ABBVIE INC.21$414
PFIZER INC.8$138
Boehringer Ingelheim Pharmaceuticals, Inc.5$124
AstraZeneca Pharmaceuticals LP4$80
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$56
GlaxoSmithKline, LLC.3$52
Boston Scientific Corporation2$46
Lilly USA, LLC2$44
MEDICOMP INC2$39
Novo Nordisk Inc1$25

Products named: QULIPTA, JARDIANCE, PREVNAR 20, UBRELVY, XIFAXAN, TRELEGY ELLIPTA, FARXIGA, WATCHMAN FLX.

Industry payments across NY — which companies pay providers there.